fig3

Nonviral cryoglobulinemic vasculitis: an updated review for clinical practice

Figure 3. Treatment of cryoglobulinemic vasculitis. In all cases, when an underlying disorder is identified, appropriate disease-specific therapy should be initiated. Plasma exchange is also recommended in cases with symptomatic hyperviscosity syndrome. CNS: Central nervous system; CYC: cyclophosphamide; DAA: direct-acting antivirals; DAH: diffuse alveolar hemorrhage; GC: glucocorticoids; GN: glomerulonephritis; HBV: hepatitis B virus; HCV: hepatitis C virus; MGUS: monoclonal gammopathy of unknown significance; MGRN: monoclonal gammopathy of renal significance; RTX: rituximab.

Vessel Plus
ISSN 2574-1209 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/